Achieve Life Sciences Reports Q3 Financial Results with $12.1 Million Net Loss
Achieve Life Sciences (NASDAQ: QUIT) has released its third-quarter financial results, reporting a net loss of $12.1 million. The company's total operating expenses for the quarter reached $20.5 million as it continues to navigate its clinical development stages. Despite the quarterly loss, market analysts have noted that the company's core thesis remains intact. Recent developments include the appointment of Benjamin Halladay as Chief Financial Officer and ongoing interest from Stifel regarding the potential of the smoking cessation drug candidate, cytisinicline.
Tickers: $ACHV
Topics: financial results net loss operating expenses
Read the full article at Seeking Alpha
Part of the story Achieve Life Sciences Reports Q3 Financial Results with $12.1 Million Net Loss (3 articles)